Parents have been grappling with fears of sending unvaccinated children to schools and colleges which are gradually reopening across the country. Now, they are likely filled with hopes and questions, after Bharat Biotech’s coronavirus jab Covaxin was recently recommended for emergency use in children between 2-18 years by the subject expert committee (SEC) of the Central Drugs Standard Control Organization (CDSCO). 

At present, Covaxin is a part of the national immunisation programme for adults only. While the manufacturer awaits the final nod from the Drugs Controller General of India (DCGI) to launch the jabs for children, Mid-day invited three experts to explain the nuances of vaccination for children, especially those who are immunocompromised.